Content area

|
|

Udredning og behandling af analcancer

Hæmatoxylin-eosin-farvet snit fra biopsi i analkanalen. Helt til højre ses normalt pladeepitel, mens den resterende del er domineret af et keratiniserende planocellulært karcinom.
Forfatter(e)
Anna-Camilla Ellemann1 & Eva Serup-Hansen2 1) Kirurgisk Afdeling, Sjællands Universitetshospital, Køge 2) Onkologisk Afdeling, Herlev Hospital Ugeskr Læger 2018;180:V01170056
Reference: 
Ugeskr Læger 2018;180:V01170056
Blad nummer: 
Sidetal: 
2-4
Work-up and treatment of anal cancer
The incidence of anal cancer is increasing. The primary treatment consists of radiotherapy concomitant with chemotherapy. Short- and long-term side effects are common, and supportive care during treatment and rehabilitation after treatment is necessary. Locoregional recurrence is treated with an abdominoperineal resection with sigmoideostomia and/or lymph node exairesis. Staging and treatment is done centralized. The prognosis has improved over the latest 10-20 years with a long-term overall survival of > 70% after primary therapy and approximately 50% after surgical treatment for recurrence.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frederik Winsløw | 22/01
2 kommentarer
af Helle Borgstrøm | 22/01
10 kommentarer
af Martin Lindhardt Nielsen | 22/01
1 Kommentar
af Kurt Håkonsson | 19/01
4 kommentarer
af Erik Kristensen | 17/01
20 kommentarer
af Thomas Michael Dan Aru | 17/01
4 kommentarer
af Claus Bo Svenningsen | 15/01
1 Kommentar